Literature DB >> 12213825

Dual regulation of phosphorylation and dephosphorylation of C/EBPbeta modulate its transcriptional activation and DNA binding in response to growth hormone.

Graciela Piwien-Pilipuk1, Ormond MacDougald, Jessica Schwartz.   

Abstract

The phosphorylation state of transcription factors is a critical determinant of their function. C/EBPbeta occurs in cells as the transcriptional activator liver-enriched activating protein (LAP) and in the truncated form liver-enriched inhibitory protein (LIP) that inhibits transcription. Analysis of C/EBPbeta phosphorylation by isoelectric focusing (IEF) shows that LAP is present in multiple forms, each with a different degree of phosphorylation in 3T3-F442A fibroblasts. Growth hormone (GH) treatment induces a new band near the negative pole, consistent with GH-promoted dephosphorylation of LAP. In addition, bands near the positive pole are rapidly and transiently induced, suggesting that GH also stimulates phosphorylation at some site(s) on LAP. C/EBPbeta contains a highly conserved MAPK consensus site that corresponds to Thr(188) in murine (m) LAP and Thr(37) in mLIP. Immunoblotting with antiphosphopeptide antibodies specific for Thr(188/37) of C/EBPbeta (anti-P-C/EBPbeta) shows that GH rapidly and transiently promotes phosphorylation of mLAP and mLIP on the MAPK site. MEK inhibitors prevent this GH-promoted phosphorylation of LAP and LIP, suggesting that such phosphorylation depends on GH-activated MAPK signaling. Mutation of Thr(235) to Ala in the homologous MAPK site of human (h) LAP (hLAPT235A) inhibits transcription mediated by the c-fos promoter in response to GH, indicating that phosphorylation at the MAPK site is required for LAP to be transcriptionally active in the context of GH-stimulated activation of the c-fos promoter. Complexes bound to the c-fos C/EBP site transiently contain C/EBPbeta phosphorylated at the MAPK site. As phosphorylation subsides, the binding of less transcriptionally active forms of LAP increases, consistent with the transient nature of c-fos stimulation by GH and other growth factors. Thus, both phosphorylation and dephosphorylation of C/EBPbeta, in response to a single physiological stimulus such as GH, coordinately modulate the ability of C/EBPbeta to activate transcription by modulating its DNA binding activity and its transactivation capacity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213825     DOI: 10.1074/jbc.M206886200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  The molecular scaffold kinase suppressor of Ras 1 (KSR1) regulates adipogenesis.

Authors:  Robert L Kortum; Diane L Costanzo; Jamie Haferbier; Steven J Schreiner; Gina L Razidlo; Ming-Hoi Wu; Deanna J Volle; Toshiyuki Mori; Hiroshi Sakaue; Nina V Chaika; Oleg V Chaika; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

2.  Regulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3.

Authors:  Ewa Marcinkowska; Edward Garay; Elzbieta Gocek; Agnieszka Chrobak; Xuening Wang; George P Studzinski
Journal:  Exp Cell Res       Date:  2006-04-19       Impact factor: 3.905

3.  TRB3 blocks adipocyte differentiation through the inhibition of C/EBPbeta transcriptional activity.

Authors:  Olivier Bezy; Cecile Vernochet; Stephane Gesta; Stephen R Farmer; C Ronald Kahn
Journal:  Mol Cell Biol       Date:  2007-07-23       Impact factor: 4.272

Review 4.  CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection.

Authors:  Yujie Liu; Michael R Nonnemacher; Brian Wigdahl
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

5.  RSK-mediated phosphorylation in the C/EBP{beta} leucine zipper regulates DNA binding, dimerization, and growth arrest activity.

Authors:  Sook Lee; Jon D Shuman; Tad Guszczynski; Krisada Sakchaisri; Thomas Sebastian; Terry D Copeland; Maria Miller; Michael S Cohen; Jack Taunton; Robert C Smart; Zhen Xiao; Li-Rong Yu; Timothy D Veenstra; Peter F Johnson
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

6.  Loss of c/EBP-beta activity promotes the adaptive to apoptotic switch in hypoxic cortical neurons.

Authors:  Marc W Halterman; Christopher De Jesus; David A Rempe; Nina F Schor; Howard J Federoff
Journal:  Mol Cell Neurosci       Date:  2008-02-13       Impact factor: 4.314

7.  MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells.

Authors:  Maroof Alam; Rehan Ahmad; Hasan Rajabi; Akriti Kharbanda; Donald Kufe
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

8.  C/EBPbeta regulation in lipopolysaccharide-stimulated macrophages.

Authors:  Michelle N Bradley; Liang Zhou; Stephen T Smale
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

9.  C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway.

Authors:  Natasa Anastasov; Irina Bonzheim; Martina Rudelius; Margit Klier; Therese Dau; Daniela Angermeier; Justus Duyster; Stefania Pittaluga; Falko Fend; Mark Raffeld; Leticia Quintanilla-Martinez
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

10.  Daxx is a transcriptional repressor of CCAAT/enhancer-binding protein beta.

Authors:  Nils Wethkamp; Karl-Heinz Klempnauer
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.